Table 2. Univariate log-rank and multivariate analyses for disease-specific and metastasis-free survivals in upper urinary tract urothelial carcinoma.
Parameter | Category | Case No. | Disease-specific Survival | Metastasis-free Survival | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||||||
No. of event | p-value | R.R. | 95% C.I. | p-value | No. of event | p-value | R.R. | 95% C.I. | p-value | |||
Gender | Male | 158 | 28 | 0.8286 | - | - | - | 32 | 0.7904 | - | - | - |
Female | 182 | 33 | - | - | - | 38 | - | - | - | |||
Age (years) | < 65 | 138 | 26 | 0.9943 | - | - | - | 30 | 0.8470 | - | - | - |
≥ 65 | 202 | 35 | - | - | - | 40 | - | - | - | |||
Tumor side | Right | 177 | 34 | 0.7366 | - | - | - | 38 | 0.3074 | - | - | - |
Left | 154 | 26 | - | - | - | 32 | - | - | - | |||
Bilateral | 9 | 1 | - | - | - | 0 | - | - | - | |||
Tumor location | Renal pelvis | 141 | 24 | 0.0079* | 1 | - | 0.873 | 31 | 0.0659 | - | - | - |
Ureter | 150 | 22 | 0.770 | 0.413–1.435 | 25 | - | - | - | ||||
Renal pelvis & ureter | 49 | 15 | 1.331 | 0.369–4.803 | 14 | - | - | - | ||||
Multifocality | Single | 273 | 48 | 0.0026* | 1 | - | 0.012* | 52 | 0.0127* | 1 | - | 0.005* |
Multifocal | 62 | 18 | 2.658 | 1.241–5.692 | 18 | 2.201 | 1.288–6.003 | |||||
Primary tumor (T) | Ta | 89 | 2 | < 0.0001* | 1 | - | 0.040* | 4 | < 0.0001* | 1 | - | 0.275 |
T1 | 92 | 9 | 3.562 | 0.757–16.746 | 15 | 2.140 | 0.143–2.384 | |||||
T2-T4 | 159 | 50 | 4.004 | 0.869–18.459 | 51 | 3.938 | 0.047–3.136 | |||||
Nodal metastasis | Negative (N0) | 312 | 42 | < 0.0001* | 1 | - | < 0.001* | 55 | < 0.0001* | 1 | - | 0.001* |
Positive (N1-N2) | 28 | 19 | 4.862 | 2.622–9.017 | 15 | 2.711 | 1.465–5.016 | |||||
Histological grade | Low grade | 56 | 4 | 0.0215* | 1 | - | 0.073 | 3 | 0.0027* | 1 | - | 0.034* |
High grade | 284 | 57 | 2.740 | 0.912–8.233 | 67 | 3.636 | 1.105–11.965 | |||||
Vascular invasion | Absent | 234 | 24 | < 0.0001* | 1 | - | 0.316 | 26 | < 0.0001* | 1 | - | 0.010* |
Present | 106 | 37 | 1.362 | 0.745–2.493 | 44 | 2.225 | 1.214–4.075 | |||||
Perineural invasion | Absent | 321 | 50 | < 0.0001* | 1 | - | < 0.001* | 61 | < 0.0001* | 1 | - | 0.009* |
Present | 19 | 11 | 4.049 | 1.924–8.521 | 9 | 2.705 | 1.282–5.706 | |||||
Mitotic rate (per 10 high power fields) | < 10 | 173 | 27 | 0.167 | - | - | - | 30 | 0.0823 | - | - | - |
> = 10 | 167 | 34 | - | - | - | 40 | - | - | - | |||
DPP4 expression | Low | 170 | 11 | < 0.0001* | 1 | - | 0.028* | 12 | < 0.0001* | 1 | - | 0.031* |
High | 170 | 50 | 2.383 | 1.099–5.167 | 58 | 2.048 | 1.068–3.926 |
* Statistically significant.